C H Benes

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics
    Li Chen
    Center for Molecular Therapeutics, Center for Cancer Research, Massachusetts General Hospital, and Harvard Medical School, CNY 149 Rm7308, Thirteenth St Charlestown, MA 02129, USA
    BMC Cancer 13:93. 2013
  2. pmc Functionalizing genomic data for personalization of medicine
    C H Benes
    The Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts, USA
    Clin Pharmacol Ther 93:309-11. 2013

Collaborators

  • Li Chen
  • Lynda Stuart
  • Gaurav K Varshney
  • Shawn Burgess
  • Mark Borowsky
  • Emmett V Schmidt
  • Toshiro K Ohsumi
  • Anahita Dastur
  • Adam Lacy-Hulbert

Detail Information

Publications2

  1. pmc Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics
    Li Chen
    Center for Molecular Therapeutics, Center for Cancer Research, Massachusetts General Hospital, and Harvard Medical School, CNY 149 Rm7308, Thirteenth St Charlestown, MA 02129, USA
    BMC Cancer 13:93. 2013
    ..For these reasons developing experimental strategies that could be used to understand, identify and predict mechanisms of resistance in different malignant cells would be a major advance...
  2. pmc Functionalizing genomic data for personalization of medicine
    C H Benes
    The Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts, USA
    Clin Pharmacol Ther 93:309-11. 2013
    ..Using the example of cancer genomics, this article focuses on systems-biology approaches to inform the development of personalized medicine...